BIOMAT Database Logo BIOMAT Database Logo

Clinical spectrum of mucolipidosis type IV. 1988

R Weitz, and G Kohn

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D009081 Mucolipidoses A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) Cherry Red Spot Myoclonus Syndrome,Ganglioside Sialidase Deficiency Disease,I-Cell Disease,Lipomucopolysaccharidosis,Mucolipidosis,Myoclonus Cherry Red Spot Syndrome,Pseudo-Hurler Polydystrophy,Sialidosis,Cherry Red Spot-Myoclonus Syndrome,Deficiency Disease, Ganglioside Sialidase,Glycoprotein Neuraminidase Deficiency,Inclusion Cell Disease,Mucolipidosis I,Mucolipidosis II,Mucolipidosis III,Mucolipidosis III Alpha Beta,Mucolipidosis IIIa,Mucolipidosis IV,Mucolipidosis Type 1,Mucolipidosis Type I,Mucolipidosis Type II,Mucolipidosis Type III,Mucolipidosis Type IV,Myoclonus-Cherry Red Spot Syndrome,Psuedo-Hurler Disease,Sialolipidosis,Type I Mucolipidosis,Type II Mucolipidosis,Type III Mucolipidosis,Type IV Mucolipidosis,Deficiencies, Glycoprotein Neuraminidase,Deficiency, Glycoprotein Neuraminidase,Glycoprotein Neuraminidase Deficiencies,I Cell Disease,I-Cell Diseases,Inclusion Cell Diseases,Lipomucopolysaccharidoses,Mucolipidoses, Type I,Mucolipidoses, Type II,Mucolipidoses, Type III,Mucolipidoses, Type IV,Mucolipidosis, Type I,Mucolipidosis, Type II,Mucolipidosis, Type III,Mucolipidosis, Type IV,Polydystrophy, Pseudo-Hurler,Pseudo Hurler Polydystrophy,Psuedo Hurler Disease,Psuedo-Hurler Diseases,Sialidoses,Sialolipidoses,Type I Mucolipidoses,Type II Mucolipidoses,Type III Mucolipidoses,Type IV Mucolipidoses
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D003318 Corneal Opacity Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque. Leukoma,Corneal Opacities,Leukomas,Opacities, Corneal,Opacity, Corneal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R Weitz, and G Kohn
Mucolipidosis type IV: clinical spectrum and natural history.
June 1987, Pediatrics,
R Weitz, and G Kohn
Mucolipidosis type IV.
July 2001, Molecular genetics and metabolism,
R Weitz, and G Kohn
Mucolipidosis type IV: clinical manifestations and natural history.
December 1991, American journal of medical genetics,
R Weitz, and G Kohn
Mucolipidosis type IV: an update.
November 2011, Molecular genetics and metabolism,
R Weitz, and G Kohn
The neurogenetics of mucolipidosis type IV.
August 2002, Neurology,
R Weitz, and G Kohn
Constitutive achlorhydria in mucolipidosis type IV.
February 1998, Proceedings of the National Academy of Sciences of the United States of America,
R Weitz, and G Kohn
Quantitative neuroimaging in mucolipidosis type IV.
February 2014, Molecular genetics and metabolism,
R Weitz, and G Kohn
Mucolipidosis type IV: ganglioside sialidase deficiency.
October 1979, Biochemical and biophysical research communications,
R Weitz, and G Kohn
Mitochondrial aberrations in mucolipidosis Type IV.
December 2006, The Journal of biological chemistry,
R Weitz, and G Kohn
Mucolipidosis type IV: characteristic MRI findings.
August 1998, Neurology,
Copied contents to your clipboard!